Lin G H, Chen W Y, Chen C M, Cheng X, Zhou B H, Ji J S
Department of Radiology, Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
Zhonghua Yi Xue Za Zhi. 2022 Jun 21;102(23):1753-1759. doi: 10.3760/cma.j.cn112137-20220101-00006.
To develop a model combined with dual-energy CT quantitative parameters and conventional CT features for evaluating the expression level of Ki-67 in invasive breast cancer. A total of 191 patients with histologically confirmed invasive breast cancer in Lishui Central Hospital from March 2019 to December 2020, were retrospectively enrolled, all of them were females, aged from 25 to 77 (53.2±11.3) years. All patients underwent preoperative non-contrast chest and contrast-enhanced Dual energy CT scans, and the normalized iodine concentration (NIC) of lesions on arterial and venous phase, spectral curve slope (λ), and normalized effective atomic number (nZ) were measured and calculated, and their conventional CT characteristics were assessed. According to the results of immunohistochemistry (IHC), the patients were divided into Ki-67 high expression group (=129 patients) and low expression group (=62 patients) level. The differences in clinical data, conventional CT characteristics and dual-energy CT quantitative parameters between the two groups were analyzed. The receiver operating characteristic curve (ROC) curve was conducted to assess the efficacy of each individual model and joint model in evaluating Ki-67 expression levels, and the area under the curve (AUC), sensitivity, specificity, and accuracy were calculated, respectively. In the analysis of CT features, the longest diameter, shape and enhancement pattern of the tumor were significantly difference between the two groups (all <0.05). The NIC, nZ on the arterial phase and NIC, nZ and λ [(,)] on the venous phase were higher in the high Ki-67 expression group compared to the low expression group [0.13 (0.12, 0.16) vs 0.11 (0.08, 0.14), 0.71 (0.70, 0.75) vs 0.70 (0.67, 0.72), 0.40 (0.32, 0.48) vs 0.23 (0.17, 0.32), 3.10 (2.58, 3.63) vs 2.86 (2.19, 3.48), 0.88 (0.85, 0.92) vs 0.85 (0.84, 0.86), all <0.05]. The logistic regression model, which integrated significant conventional CT features and dual-energy CT quantitative parameters, demonstrated the highest diagnostic performance for assessing Ki-67 expression levels, with an AUC of 0.924, sensitivity of 88.37%, specificity of 83.87%, and accuracy of 86.91%; the AUC of the dual-energy CT parameter model was 0.908, sensitivity of 82.17%, specificity of 88.71%, and accuracy of 84.29%. Though the diagnostic efficacy was no significant difference (=0.238), both models showed superior to the conventional CT feature model (all <0.001). A dual-energy CT quantitative parameter combined with a conventional CT feature model was successfully constructed, which has a good evaluation performance on the expression level of Ki-67 in invasive breast cancer.
构建一种结合双能CT定量参数和传统CT特征的模型,用于评估浸润性乳腺癌中Ki-67的表达水平。回顾性纳入2019年3月至2020年12月在丽水市中心医院组织学确诊为浸润性乳腺癌的191例患者,均为女性,年龄25至77岁(53.2±11.3岁)。所有患者均接受术前非增强胸部及双能CT增强扫描,测量并计算病变在动脉期和静脉期的归一化碘浓度(NIC)、能谱曲线斜率(λ)和归一化有效原子序数(nZ),并评估其传统CT特征。根据免疫组织化学(IHC)结果,将患者分为Ki-67高表达组(=129例患者)和低表达组(=62例患者)。分析两组患者的临床资料、传统CT特征和双能CT定量参数的差异。绘制受试者操作特征曲线(ROC)以评估各单一模型和联合模型评估Ki-67表达水平的效能,并分别计算曲线下面积(AUC)、敏感性、特异性和准确性。在CT特征分析中,两组患者肿瘤的最长径、形态和强化方式差异有统计学意义(均<0.05)。与低表达组相比,高Ki-67表达组动脉期的NIC、nZ以及静脉期的NIC、nZ和λ[(,)]更高[0.13(0.12,0.16)对0.11(0.08,0.14);0.71(0.70,0.75)对0.70(0.67,0.72);0.40(0.32,0.48)对0.23(0.17,0.32);3.10(2.58,3.63)对2.86(2.19,3.48);0.88(0.85,0.92)对0.85(0.84,0.86),均<0.05]。整合了显著传统CT特征和双能CT定量参数的逻辑回归模型在评估Ki-67表达水平方面表现出最高的诊断效能,AUC为0.924,敏感性为88.37%,特异性为83.87%,准确性为86.91%;双能CT参数模型的AUC为0.908,敏感性为82.17%,特异性为88.71%,准确性为84.29%。尽管诊断效能差异无统计学意义(=0.238),但两种模型均优于传统CT特征模型(均<0.001)。成功构建了一种结合双能CT定量参数和传统CT特征的模型,其对浸润性乳腺癌中Ki-67的表达水平具有良好的评估性能。